Hepatitis concept is a popular track with higher attention recently, but many stockholders don't know what are the hepatitis concept stocks, and today Wealth Management has compiled a list of leading hepatitis concept stocks for your reference.
Pientzehuang (600436)(600436)
The main business of Zhangzhou Pientzehuang Pharmaceutical Company Limited is pharmaceutical manufacturing industry, cosmetic, daily chemical products and health care products, health care food, and pharmaceutical circulation industry. The main products of the company are Pientzehuang and its series of products. Pientzehuang's long history, profound cultural background and remarkable curative effects highlight its unique brand advantages. Pientzehuang, the traditional precious Chinese patent medicine exclusively produced by the company, originated from the court, flourished in the temple, was handed down in the folklore and developed in the contemporary times, and has formed an excellent reputation due to its unique and miraculous efficacy, and is regarded as "National Treasure and Famous Medicine" by the domestic and foreign traditional Chinese medicine circles.
Price (301257)
Price (Shanghai) Pharmaceutical Technology Development Co., Ltd. provides SMO services to domestic and foreign pharmaceutical companies, medical device companies, and some clinical research and development of health-related products. The main service is to provide customers with SMO full-process services to obtain revenue, profit and cash flow. In terms of staff size, the Company is in the first tier of the SMO industry. The Company has more than 2,100 professional business staff, serves more than 600 clinical trial organizations, with a service scope covering more than 140 cities across the country, and possesses a cumulative experience of more than 1,300 international multi-center and domestic clinical projects for new drugs of Class I. The Company's clients include world-renowned foreign companies, medical device companies, and some health-related products. Our clients include world-renowned foreign pharmaceutical companies and domestic leading new drug R&D companies. We provide clinical trial site management services for well-known multinational pharmaceutical companies including Pfizer, Roche, Novartis, Johnson & Johnson, AbbVie and Eli Lilly, etc. Our SMO services are of high quality and efficiency, and are at an advanced level of the same industry in line with the international...
Golden Med (603882)(603882)
Guangzhou Golden Medical Laboratory Group Co., Ltd. is a third-party medical testing and pathology diagnostic business as the core of high-tech service enterprises, is committed to providing medical testing and diagnostic information for medical institutions at all levels across the country to provide services in line with international standards of integration of medical testing and diagnostic information. The main services provided by the company are as follows: medical testing and pathology diagnostics, non-medical testing, reagent sales, reagent production, testing information services, medical cold chain logistics. Guangzhou Goldcorp was recognized for the first time as a "National Intellectual Property Model Enterprise", the highest honor in national intellectual property management. The company's quality management system covers ISO/IEC17025, ISO9001, ISO15189, CMA, CAP-LAP and so on.
Hualan Vaccine (301207)
Hualan Bio (002007) Vaccine Co., Ltd. is a high and new technology enterprise specializing in the research, development, production, and sales of human vaccines. The company's listed products mainly include influenza virus lysate vaccine, tetravalent influenza virus lysate vaccine, influenza A (H1N1) virus lysate vaccine, recombinant hepatitis B vaccine (Hansenula polymorpha) as well as ACYW135 group meningococcal polysaccharide vaccine, group A C meningococcal polysaccharide vaccine, etc.; the products that have been approved for clinical trials or have passed the clinical to be registered for listing mainly include human rabies vaccine ( Vero cell), adsorbed tetanus vaccine, lyophilized group A and C meningococcal conjugate vaccine, H7N9 influenza virus lysate vaccine, H7N9 influenza whole virus inactivated vaccine, and adsorbed cell-free combined vaccine, etc.; products in the stage of preclinical research include a new type of inactivated coronavirus vaccine (VERO cell), a recombinant coronavirus pneumonia vaccine (recombinant human adenovirus 5 vector... Vector...
Dian Diagnostics (300244)(300244)
Dian Diagnostics Technology Group Inc.'s main business is medical diagnostic services and in vitro diagnostic product sales. The company's main products and services are diagnostic services, diagnostic products, cold chain logistics, health checkups, and financial leasing. In terms of oncology discipline, the company continues to deepen the discipline construction and marketing force building in parallel, in September in the CSCO Academic Annual Meeting won the second place in the CSCO annual meeting of the best satellite meeting (genetic testing group). We have obtained three Class III registration certificates, one Class II registration certificate, 27 Class I filed products, and one Class III diagnostic product is currently in the registration process.
East China Pharmaceutical (000963)(000963)
East China Pharmaceutical Co., Ltd.'s main business covers the whole industry chain of pharmaceuticals, with the pharmaceutical industry as the leading industry, and at the same time expanding the pharmaceutical business and the medical aesthetic industry, integrating the research and development of pharmaceuticals, production and distribution. The medical aesthetic industry focuses on the research, development, production and sales of non-surgical mainstream medical aesthetic products, such as facial fillers, body contouring, buried threads and energy source devices. The Company's main products are mainly western and Chinese medicine drugs, medical devices, differentiated sodium hyaluronate full product portfolio, collagen stimulators, botulinum toxin type A, buried threads, and energy source devices. The company's cyclosporine and acarbose two microbial drugs have won the second prize of the National Science and Technology Progress, pharmaceutical business is one of the top in Zhejiang Province, the strength of the comprehensive large-scale pharmaceutical industry service providers.
Guang Shengtang (300436)(300436)
Fujian Guangshengtang Pharmaceutical Co., Ltd.'s main business is the research and development, production and sales of nucleoside anti-hepatitis B virus drugs; the company's main products are anti-hepatitis B virus drugs, hepatoprotective and liver-protecting drugs, drugs for the digestive system, respiratory system drugs, cardiovascular The company's main products are anti-hepatitis B virus drugs, hepatoprotective drugs, digestive system drugs, respiratory system drugs, cardiovascular drugs, and medical testing services; the company is currently a domestic pharmaceutical enterprise focusing on the field of liver health, and it is the only pharmaceutical enterprise in China that owns four major clinically preferred anti-hepatitis B virus drugs, namely, adefovir, lamivudine, entecavir, and tenofovir, simultaneously.
Hualan Bio(002007)
Hualan Bioengineering Co., Ltd. is a company mainly engaged in the production and sales of blood products and bacterial vaccines. The company's main products include human albumin, intravenous human immunoglobulin (PH4), human prothrombin complex, human coagulation factor VIII and so on. At present, the company's production scale and market share are in the forefront of the industry, and it has become a leading enterprise in the industry of blood products and vaccines. In 1998, the company was the first one to pass the GMP certification of the blood products industry, and it is a large-scale state-designated manufacturer of biologics, and it is in a leading position among the enterprises of the same industry in the country. The company has undertaken a number of national, provincial and municipal science and technology projects, including freeze-dried human fibrin glue for surgical use, which was included in the national 863 project. In 2009, the company relied on the company's scientific research strength in the influenza A (H1N1) epidemic in the world's first developed influenza A (H1N1) vaccine, the company's influenza A vaccine clinical research report published in the world's top medical...
CHENGDA PHARMACEUTICALS(301201)
CHENGDA PHARMACEUTICALS Co., Ltd. is mainly dedicated to providing key pharmaceutical intermediates CDMO services for multinational pharmaceutical companies and pharmaceutical research and development institutes, and engages in the research and development, production and sales of L-carnitine series products. The main products and services of the company are CDMO business, L-carnitine series products and APIs. The company is a high-tech enterprise, with a provincial high-tech enterprise research and development center, a provincial enterprise technology center, and a postdoctoral workstation in Zhejiang Province. Since its establishment, the company has been attaching great importance to the research and development of new products, new processes and technological innovation, and has established a market demand-oriented R&D management system. Through continuous R&D and innovation, the company's products have been awarded "National Key New Products", "National Torch Program", "National Ministry of Commerce R&D Project" and many other national and provincial level The company has won a number of national and provincial scientific research achievements and honors.
Jianfan Bio(300529)(300529)
Jianfan Bio-technology Group Co., Ltd. is mainly engaged in the research and development of blood perfusion related products, production and sales. The main products are hemoperfusion devices, blood purification equipment, hemodialysis powder products. The company is a national high-tech enterprise, "the creation of high-performance blood purification medical adsorbent resin" project was "2009 National Scientific and Technological Progress Second Prize", to undertake two "national key new product project", three "national key new product project" and "national key new product project", and "national key new product project". The company has undertaken two "National Key New Product Projects" and three "National Torch Program Projects", and has been recognized as a "Key High-Tech Enterprise under the National Torch Program".